Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Late-Stage Pipeline

90%

9 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment reporting

Analytics

Phase 3
5(50.0%)
Phase 4
4(40.0%)
Phase 2
1(10.0%)
10Total
Phase 3(5)
Phase 4(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT07646223Phase 2Not Yet Recruiting

Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis

Role: lead

NCT07575009Phase 3Recruiting

Continuous Antibiotic Infusion In Children

Role: lead

NCT04026230Phase 3Unknown

Impact of Atorvastatin on Prostate Cancer Progression During ADT

Role: lead

SYF0f24a0755a59457a86009f5c37337f89Phase 4Unknown

Selän alueen poikkeava aktiivisuus servikaalisessa dystoniassa

Role: lead

SYF3a23a37607e2421d99691930d27b3069Phase 3Active Not Recruiting

DupuytrEn Treatment EffeCtiveness Trial (DETECT)

Role: lead

SYF47df4ee017ac43ee84f840638a40faeePhase 4Recruiting

Monitoring of neuromuscular blockade during general anaesthesia

Role: lead

SYF6b9988cb18b94ba6883d7b84e729b9b1Phase 3Not Yet Recruiting

LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospective, Randomized, Controlled Trial

Role: lead

SYF746dd51a01764c2287987a75c2241c34Phase 4Unknown

Laparoskooppisen paksusuoliresektion leikkauksen jälkeisten kivunhoitomenetelmien vertailu nykytiedon valossa

Role: lead

SYFabd907ca444943c0824d7b9410f59701Phase 3Recruiting

Measuring Oncological Value of Exercise and Statin (MOVES)

Role: lead

SYFfb70584c724548769314b9c5e0c53f7cPhase 4Not Yet Recruiting

Lantiolihaspuudutuksen vaikutus munuaisen poistoleikkauksen jälkeiseen kivun hoitoon ja toipumiseen

Role: lead

All 10 trials loaded